bioRxiv · 10.1101/2022.12.21.521379
O-GlcNAc glycosylation orchestrates fate decision and niche function of bone marrow stromal progenitors
Abstract
In mammals, interactions between the bone marrow (BM) stroma and hematopoietic progenitors contribute to bone-BM homeostasis. Perinatal bone growth and ossification provide a microenvironment for the transition to definitive hematopoiesis; however, mechanisms and interactions orchestrating the development of skeletal and hematopoietic systems remain largely unknown. Here, we establish intracellular O-linked {beta}-N-acetylglucosamine (O-GlcNAc) modification as a posttranslational switch that dictates the differentiation fate and niche function of early BM stromal cells (BMSCs). By modifying and activating RUNX2, O-GlcNAcylation promotes osteogenic differentiation of BMSCs and stromal IL-7 expression to support lymphopoiesis. In contrast, C/EBP{beta}-dependent marrow adipogenesis and expression of myelopoietic stem cell factor (SCF) is inhibited by O-GlcNAcylation. Ablating O-GlcNAc transferase (OGT) in BMSCs leads to impaired bone formation, increased marrow adiposity, as well as defective B-cell lymphopoiesis and myeloid overproduction in mice. Thus, the balance of osteogenic and adipogenic differentiation of BMSCs is determined by reciprocal O-GlcNAc regulation of transcription factors, which simultaneously shapes the hematopoietic niche.
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Zhang, Z., Huang, Z., Awad, M., Elsalanty, M., Cray, J., Ball, L. E., Maynard, J., Burlingame, A. L., Zeng, H., Mansky, K. C., Ruan, H.-B.. 2022-12-21. O-GlcNAc glycosylation orchestrates fate decision and niche function of bone marrow stromal progenitors. https://doi.org/10.1101/2022.12.21.521379
Cite the original work for its findings. Save a collection to share your selection of sources.